Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial

Journal:

The Lancet

Published:

2026-05-12

DOI:

10.1016/s0140-6736(26)00656-2

Affiliations:

8

Authors:

13

Go to article

Institutions	Authors	Share
Lilly, United States of America (USA)	7.000000	0.54
The University of Texas Health Science Center at Houston (UTHealth), United States of America (USA)	1.000000	0.08
Weill Cornell Medicine, United States of America (USA)	1.000000	0.08
Louisville Metabolic and Atherosclerosis Research Center (L-MARC), United States of America (USA)	1.000000	0.08
University College Dublin (UCD), Ireland	1.000000	0.08
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	1.000000	0.08
University of Toronto (U of T), Canada	0.500000	0.04
Wharton Medical Clinic, Canada	0.500000	0.04

Interested in Nutrition and Dietetics?